Search research articles
Contact Us
Filters
Showing results (91-100 of 217) with videos related to
Page
of 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Blood
|
October 11, 2007
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
Hisaki Fujii, Geoff Cuvelier, Kevin She, et al.
The New England Journal of Medicine
|
October 30, 2014
One-unit versus two-unit cord-blood transplantation for hematologic cancers
John E Wagner, Mary Eapen, Shelly Carter, et al.
Journal of Clinical Immunology
|
November 13, 2014
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene
Koichi Oshima, Kohsuke Imai, Michael H Albert, et al.
Transplantation and Cellular Therapy
|
May 23, 2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update
Stephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, et al.
Bone Marrow Transplantation
|
June 7, 2018
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Helene M Schoemans, Stephanie J Lee, James L Ferrara, et al.
The Lancet. Oncology
|
January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Irwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology
|
January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
Irwin Walker, Tony Panzarella, Stephen Couban, et al.
Transplantation and Cellular Therapy
|
January 24, 2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Blachy J Dávila Saldaña, Kirk R Schultz, Archana Ramgopal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2012
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease
Jeanne M Palmer, Stephanie J Lee, Xiaoyu Chai, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 217) with videos related to
Sort By:
Page
of 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea-Banacloche, Krishna V Komanduri, Paul Carpenter, et al.
Blood
|
October 11, 2007
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
Hisaki Fujii, Geoff Cuvelier, Kevin She, et al.
The New England Journal of Medicine
|
October 30, 2014
One-unit versus two-unit cord-blood transplantation for hematologic cancers
John E Wagner, Mary Eapen, Shelly Carter, et al.
Journal of Clinical Immunology
|
November 13, 2014
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene
Koichi Oshima, Kohsuke Imai, Michael H Albert, et al.
Transplantation and Cellular Therapy
|
May 23, 2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update
Stephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, et al.
Bone Marrow Transplantation
|
June 7, 2018
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Helene M Schoemans, Stephanie J Lee, James L Ferrara, et al.
The Lancet. Oncology
|
January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Irwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology
|
January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
Irwin Walker, Tony Panzarella, Stephen Couban, et al.
Transplantation and Cellular Therapy
|
January 24, 2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Blachy J Dávila Saldaña, Kirk R Schultz, Archana Ramgopal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2012
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease
Jeanne M Palmer, Stephanie J Lee, Xiaoyu Chai, et al.
Page
of 22